Loading company…
Novus Diagnostics develops rapid point-of-care tests for sepsis and bloodstream infections.
Novus Diagnostics develops a bedside testing platform for sepsis that uses microfluidic electrochemical sensors and diagnostic algorithms to provide results in 15 minutes. It helps clinicians identify infections and classify pathogens. Founded in 2020 by Elaine Spain and Kellie Adamson, the company is based in Dublin, Ireland. In January 2025, it raised EUR 4.6 million co-led by Business Venture Partners, Trinity Biotech, and Irrus Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in